Nova Leap Health - CEO, Chris Dobbin
CEO, Chris Dobbin
Source: YouTube
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Nova Leap Health (NLH) is seeking to raise up to C$2 million through a non-brokered private placement
  • The company will issue up to 2,777,777 common shares at $0.72 per share
  • Proceeds will be used for acquisition and expansion purposes
  • The offering is scheduled to close on or about June 30, 2021
  • Nova Leap Health is a home health care services company working out of the U.S. and Canada
  • Nova Leap (NLH) is trading flat at $0.79 per share

Nova Leap Health (NLH) is seeking to raise up to C$2 million through a non-brokered private placement.

The company will issue up to 2,777,777 common shares at $0.72 per share and use the proceeds for acquisition and expansion purposes.

The offering is scheduled to close on or about June 30, 2021.

Nova Leap may pay a cash finder’s fee of up to 6 per cent of the proceeds raised from the offering.

Chris Dobbin, President and CEO of Nova Leap, commented,

“We continue to receive quality acquisition opportunities on a regular basis. We recently announced the best quarterly revenue results in the company’s history, and we have plans for significant growth for the remainder of the year. This funding will allow us to act quickly on acquisition opportunities as we continue to scale the business.”

Nova Leap is a home health care services company working out of the U.S. and Canada. The company achieved the #2 ranking on the 2020 Report on Business ranking of Canada’s Top Growing Companies and the #10 ranking in the 2019 TSX Venture 50 in the clean technology & life sciences sector.

Nova Leap (NLH) is trading flat at $0.79 per share as of 12:53 pm ET.

More From The Market Herald

" Hemostemix (TSXV:HEM) announces non-brokered private placement

Hemostemix (HEM) has announced a non-brokered private placement of up to 15 million units.
WELL Health - Chairman & CEO Hamed Shahbazi

" WELL Health (TSX:WELL) closes $34.5M public offering

WELL Health Technologies Corp. (WELL) has completed a bought deal public offering for proceeds of $34.5 million.

" Simply Better Brands (TSXV:SBBC) enters the weight loss category

Simply Better Brands (SBBC) has launched its entry into the weight loss category with a PureKana Keto Gummy.

" Cardiol Therapeutics (TSX:CRDL) appoints new directors

Cardiol Therapeutics (CRDL) has appointed Teri Loxam and Chris Waddick to its Board of Directors, effective immediately.